JP2009240315A5 - - Google Patents

Download PDF

Info

Publication number
JP2009240315A5
JP2009240315A5 JP2009138688A JP2009138688A JP2009240315A5 JP 2009240315 A5 JP2009240315 A5 JP 2009240315A5 JP 2009138688 A JP2009138688 A JP 2009138688A JP 2009138688 A JP2009138688 A JP 2009138688A JP 2009240315 A5 JP2009240315 A5 JP 2009240315A5
Authority
JP
Japan
Prior art keywords
hiv
sequence
peptide
deposited
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009138688A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009240315A (ja
Filing date
Publication date
Priority claimed from FR9412554A external-priority patent/FR2726006B1/fr
Priority claimed from FR9502526A external-priority patent/FR2731225B1/fr
Application filed filed Critical
Publication of JP2009240315A publication Critical patent/JP2009240315A/ja
Publication of JP2009240315A5 publication Critical patent/JP2009240315A5/ja
Withdrawn legal-status Critical Current

Links

JP2009138688A 1994-10-20 2009-06-09 Ｈｉｖ−１のｏグループ（またはサブグループ）レトロウイルス性抗原のヌクレオチド配列 Withdrawn JP2009240315A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9412554A FR2726006B1 (fr) 1994-10-20 1994-10-20 Sequences nucleotidiques codant des antigenes d'un retrovirus du type vih-1 groupe o
FR9502526A FR2731225B1 (fr) 1995-03-03 1995-03-03 Peptides de glycoproteine transmembranaire d'enveloppe et de proteine de capside du retrovirus humain du type hiv-1 et peptides presentant avec eux une parente immunologique

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2008121431A Division JP4589420B2 (ja) 1994-10-20 2008-05-07 Ｈｉｖ−１のｏグループ（またはサブグループ）レトロウイルス性抗原のヌクレオチド配列

Publications (2)

Publication Number Publication Date
JP2009240315A JP2009240315A (ja) 2009-10-22
JP2009240315A5 true JP2009240315A5 (https=) 2010-02-25

Family

ID=26231483

Family Applications (4)

Application Number Title Priority Date Filing Date
JP51369296A Expired - Lifetime JP4278174B2 (ja) 1994-10-20 1995-10-20 Ｈｉｖ−１のｏグループ（またはサブグループ）レトロウイルス性抗原のヌクレオチド配列
JP2008121431A Expired - Lifetime JP4589420B2 (ja) 1994-10-20 2008-05-07 Ｈｉｖ−１のｏグループ（またはサブグループ）レトロウイルス性抗原のヌクレオチド配列
JP2009138688A Withdrawn JP2009240315A (ja) 1994-10-20 2009-06-09 Ｈｉｖ−１のｏグループ（またはサブグループ）レトロウイルス性抗原のヌクレオチド配列
JP2010048112A Withdrawn JP2010172335A (ja) 1994-10-20 2010-03-04 Ｈｉｖ−１のｏグループ（またはサブグループ）レトロウイルス性抗原のヌクレオチド配列

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP51369296A Expired - Lifetime JP4278174B2 (ja) 1994-10-20 1995-10-20 Ｈｉｖ−１のｏグループ（またはサブグループ）レトロウイルス性抗原のヌクレオチド配列
JP2008121431A Expired - Lifetime JP4589420B2 (ja) 1994-10-20 2008-05-07 Ｈｉｖ−１のｏグループ（またはサブグループ）レトロウイルス性抗原のヌクレオチド配列

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010048112A Withdrawn JP2010172335A (ja) 1994-10-20 2010-03-04 Ｈｉｖ−１のｏグループ（またはサブグループ）レトロウイルス性抗原のヌクレオチド配列

Country Status (12)

Country Link
US (3) US6399294B1 (https=)
EP (2) EP0787191B2 (https=)
JP (4) JP4278174B2 (https=)
CN (3) CN1147586C (https=)
AT (1) ATE374253T1 (https=)
AU (3) AU715731B2 (https=)
CA (2) CA2202408C (https=)
DE (1) DE69535601T3 (https=)
DK (1) DK0787191T4 (https=)
ES (1) ES2293643T5 (https=)
PT (1) PT787191E (https=)
WO (1) WO1996012809A2 (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE374253T1 (de) * 1994-10-20 2007-10-15 Pasteur Institut Nukleotiden-sequenzen aus retroviren-antigenen hiv-i gruppe (oder untergruppe) o
DE69604051T2 (de) * 1995-01-27 1999-12-16 The Government Of The United States Of America, As Represented By The Secretary Verfahren zum sensitiven nachweis von reverser transcriptase
DE19505262C2 (de) * 1995-02-16 1998-06-18 Behring Diagnostics Gmbh Retrovirus aus der HIV-Gruppe und dessen Verwendung
FR2761993B1 (fr) * 1997-04-09 1999-05-21 Pasteur Sanofi Diagnostics Peptides synthetiques utilisables dans les essais biologiques pour la detection des infections dues aux virus vih 1 groupe 0
CZ300927B6 (cs) * 1997-04-09 2009-09-16 Bio-Rad Pasteur Syntetický peptid monomerního typu, prostredek, který ho obsahuje, zpusob imunologické in vitro kvantifikace a diagnostický kit pro použití v biologických testech pro identifikaci infekcí zpusobených viry HIV
FR2775287B1 (fr) * 1998-02-24 2000-11-24 Pasteur Sanofi Diagnostics Peptides synthetiques consensus utilisables dans les essais biologiques pour la detection des infections dues aux virus vih 1 du groupe o
EP1003878A2 (en) * 1997-07-18 2000-05-31 Innogenetics N.V. Hiv-1 group o antigens and uses thereof
US5922533A (en) * 1997-08-15 1999-07-13 Abbott Laboratories Rapid assay for simultaneous detection and differentiation of antibodies to HIV groups
US6846905B2 (en) 1997-08-15 2005-01-25 Abbott Laboratories Antigen constructs useful in the detection and differentiation of antibodies to HIV
AU2345399A (en) * 1998-01-28 1999-08-16 Universal Health-Watch, Inc. Divergent hiv-1 peptides
CN1061092C (zh) * 1998-02-27 2001-01-24 中国科学院上海生物化学研究所 白色念珠菌具有逆转录转座子结构的元件
CA2288869A1 (en) * 1998-03-04 1999-09-10 Mary Ann Childs Rapid confirmatory test for microbial infections
WO1999056128A1 (en) * 1998-04-30 1999-11-04 Universal Healthwatch, Inc. Immunoassay with mixed peptides
WO1999062945A2 (en) * 1998-06-05 1999-12-09 Peptide Solutions, Inc. Peptide antigens for detection of hiv, hcv and other microbial infections
CA2290217C (en) * 1998-11-30 2010-01-12 Ortho-Clinical Diagnostics, Inc. Peptides for the detection of hiv-1 group o
JP4824236B2 (ja) * 1999-07-09 2011-11-30 ジェン−プローブ・インコーポレーテッド 核酸増幅によるｈｉｖ−１の検出
US6818392B2 (en) 2000-12-06 2004-11-16 Abbott Laboratories Monoclonal antibodies to human immunodeficiency virus and uses thereof
EP2251442B9 (en) 2003-12-19 2012-04-25 Gen-Probe Incorporated Compositions, methods and kits for detecting the nucleic acids of HIV-1 and HIV-2
TW200613554A (en) 2004-06-17 2006-05-01 Wyeth Corp Plasmid having three complete transcriptional units and immunogenic compositions for inducing an immune response to HIV
EP2309269B1 (en) * 2004-09-08 2016-10-26 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Compositions and methods for the detection of HIV-1/HIV-2 infection.
CA2637600A1 (en) 2006-01-17 2007-07-26 Health Research, Inc. Heteroduplex tracking assay
US8405379B1 (en) 2008-09-18 2013-03-26 Luc Montagnier System and method for the analysis of DNA sequences in biological fluids
CA2817418A1 (en) * 2010-11-10 2012-05-18 Laboratorios Del Dr. Esteve, S.A. Highly immunogenic hiv p24 sequences
EP2864787B1 (en) * 2012-06-22 2017-11-01 Bio-Rad Laboratories, Inc. Human factor xiii as a normalization control for immunoassays
US9823249B2 (en) * 2012-12-12 2017-11-21 Brigham And Women's Hospital, Inc. System and method for detecting pathogens
KR102056520B1 (ko) 2017-03-24 2019-12-18 (주)셀아이콘랩 인간 섬유아세포에서 콜라겐 합성 촉진 및 콜라겐 분해 효소 활성화 억제를 유도하는 펩타이드를 함유한 화장품 조성물 및 제조방법
CN108997482B (zh) 2018-08-09 2025-09-09 东莞市朋志生物科技有限公司 用于检测hiv-1的合成肽

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5030714A (en) 1986-06-23 1991-07-09 Institut Pasteur Variant of LAV viruses
AU592258B2 (en) * 1986-12-30 1990-01-04 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Synthetic peptides which induce cellular immunity to the aids virus and aids viral proteins
NO881151L (no) * 1987-03-27 1988-09-28 Syntello Ab Syntetisk hiv-1-antigen.
CA1339363C (en) 1987-05-01 1997-08-26 Alan Ray Flesher Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use
JPH0215098A (ja) * 1987-05-18 1990-01-18 Virovahl Sa Ｈｉｖ−１感染検出用合成ペプチド杭原、その組成物およびその使用方法
US5019387A (en) * 1987-09-08 1991-05-28 Duke University Production of antibodies to HIV
AU629528B2 (en) * 1988-01-27 1992-10-08 Biochem Pharma Inc. Synthetic peptides and mixtures thereof for detecting hiv antibodies
EP0330359A3 (en) * 1988-02-25 1991-06-05 Bio-Rad Laboratories, Inc. Composition useful in the diagnosis and treating of hiv-1 infection
DE3853422T2 (de) 1988-06-09 1995-10-26 Innogenetics Nv HIV-3-Retrovirus und seine Verwendung.
WO1990007119A1 (en) * 1988-12-20 1990-06-28 Immunodiagnostics, Inc. Synthetic hiv-like peptides, their compositions and uses
GB8910145D0 (en) * 1989-05-03 1989-06-21 Connaught Lab Synthetic peptides for an hiv-1 vaccine
ZA903492B (en) * 1989-05-15 1991-02-27 Akzo Nv T-lymphotropic retrovirus monoclonal antibodies
FR2647810B1 (fr) * 1989-06-02 1994-07-22 Pasteur Institut Amorces oligonucleotidiques pour l'amplification du genome des retrovirus du type hiv-2 et siv, et leurs applications au diagnostic in vitro des infections dues a ces virus
DE3934366A1 (de) * 1989-10-14 1991-04-18 Chemotherapeutisches Forschungsinstitut Georg Speyer Haus Vakzine zum schutz vor hiv-virusinfektionen, verfahren zu ihrer herstellung und ihre verwendung als diagnostikum und immuntherapeutikum
EP0510054A1 (en) * 1990-01-05 1992-10-28 United Biomedical, Inc. Hiv-1 core protein fragments
IL99077A0 (en) 1990-08-13 1992-07-15 Merck & Co Inc New embodiments of the hiv principal neutralizing determinant and pharmaceutical compositions containing them
EP0854193A1 (en) * 1990-09-21 1998-07-22 Chiron Corporation Human retroviral packaging cell line
US7115554B1 (en) 1993-05-06 2006-10-03 Acorda Therapeutics, Inc. Methods of increasing myotube formation or survival or muscle cell mitogenesis differentiation or survival using neuregulin GGF III
JP2541030B2 (ja) * 1991-04-22 1996-10-09 富士ゼロックス株式会社 ヒドロキシインジウムフタロシアニンの新規結晶及びそれを用いた電子写真感光体
SG77551A1 (en) * 1992-03-06 2005-04-28 Innogenetics Nv Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing
DE69311764T2 (de) 1992-05-14 1998-02-05 Polymun Scient Immunbio Forsch Peptide, die Antikörper induzieren, die genetisch divergierende HIV-1 Isolationen neutralisieren
JP3207535B2 (ja) 1992-08-07 2001-09-10 森永乳業株式会社 抗酸化剤
ATE174382T1 (de) 1992-10-06 1998-12-15 Dade Behring Marburg Gmbh Retrovirus aus der hiv-gruppe und dessen verwendung
AU7101294A (en) 1993-06-07 1995-01-03 Endocon, Inc. Implant stimulated cellular immunity
CN1111540C (zh) * 1993-06-09 2003-06-18 康诺特实验室有限公司 串联的合成hiv－1肽类
FR2707091B1 (fr) * 1993-06-30 1997-04-04 Cohen Haguenauer Odile Vecteur rétroviral pour le transfert et l'expression de gènes dans des cellules eucaryotes.
ATE374253T1 (de) * 1994-10-20 2007-10-15 Pasteur Institut Nukleotiden-sequenzen aus retroviren-antigenen hiv-i gruppe (oder untergruppe) o
DE19622088A1 (de) 1996-05-31 1997-12-04 Boehringer Mannheim Gmbh Anti-HIV-Antikörper als Kontrollproben

Similar Documents

Publication Publication Date Title
JP2009240315A5 (https=)
Claireaux et al. A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike
CN102264896B (zh) 抗人流感病毒人型抗体
EP2975053B9 (en) Broadly neutralizing antibody and uses thereof
CN103476929B (zh) 抗流感病毒中和抗体及其筛选方法
JP2011524161A5 (https=)
CN104031144B (zh) 特异结合戊型肝炎病毒3、4型的抗体及其用途
CN113577257B (zh) 细粒棘球绦虫EgTeg和EgFABP1多表位疫苗及应用
CN103163299A (zh) 禽白血病双抗体夹心elisa抗原检测试剂盒
Wang et al. HIV-1 gp41 core with exposed membrane-proximal external region inducing broad HIV-1 neutralizing antibodies
CN106381288B (zh) 一种抗h3n2亚型犬流感病毒核蛋白单克隆抗体杂交瘤2d10及单克隆抗体
CN106434568B (zh) 一种抗猪流行性腹泻病毒s蛋白杂交瘤细胞株及其应用
WO2013095091A2 (en) Rsv g protein specific antibodies
RU2013143295A (ru) Способ быстрого отбора вариантов gp-120 вич
CN102775469B (zh) 甲型流感病毒核衣壳蛋白的抗原表位及其用途
Wang et al. Development and identification of porcine monoclonal antibodies against PEDV from single B cells
Zhou et al. SARS-CoV-2 hijacks neutralizing dimeric IgA for enhanced nasal infection and injury
Wang et al. Potential of conserved antigenic sites in development of universal SARS-like coronavirus vaccines
CN103030693A (zh) 高致病性禽流感的中和分子及其制备方法
Peng et al. Identification of one peptide which inhibited infectivity of avian infectious bronchitis virus in vitro
CN115087667B (zh) 特异性结合SARS-CoV-2的抗原结合蛋白
CN104193827B (zh) 一种丙型肝炎病毒第一高变区融合抗原及其应用
CN104151399A (zh) 博卡病毒(HBoV)共有的特异性表位、其应用及其抗体
WO2023148641A1 (en) Monoclonal antibodies specific to receptor binding domain of sars-cov2 and uses thereof
CN107541522A (zh) 抗埃博拉病毒gp蛋白的单克隆抗体及其应用